PubMed

Hepatic fat and inflammation in type 2 diabetes mellitus.

Saremi A, Allison M, Ditomasso D, Ge L, Anderson R, Moritz TE, Duckworth W, Abraira C, Reaven PD; for the VADT.

Metabolism. 2009 Oct 20. [Epub ahead of print]PMID: 19850309 [PubMed - as supplied by publisher]Related articles

Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis.

Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W; Veterans Affairs Diabetes Trial.

Diabetes. 2009 Nov;58(11):2642-8. Epub 2009 Aug 3.PMID: 19651816 [PubMed - in process]Related articles

Actos Now for the prevention of diabetes (ACT NOW) study.

Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D.

BMC Endocr Disord. 2009 Jul 29;9:17.PMID: 19640291 [PubMed - in process]Related articlesFree article

Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages.

Permana PA, Zhang W, Wabitsch M, Fischer-Posovszky P, Duckworth WC, Reaven PD.

Am J Physiol Endocrinol Metab. 2009 May;296(5):E1076-84. Epub 2009 Feb 24.PMID: 19240250 [PubMed - indexed for MEDLINE]Related articles

Glucose control and vascular complications in veterans with type 2 diabetes.

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD; VADT Investigators.

N Engl J Med. 2009 Jan 8;360(2):129-39. Epub 2008 Dec 17. Erratum in: N Engl J Med. 2009 Sep 3;361(10):1024-5. N Engl J Med. 2009 Sep 3;361(10):1028. PMID: 19092145 [PubMed - indexed for MEDLINE]Related articlesFree article

Pioglitazone inhibits the expression of inflammatory cytokines from both monocytes and lymphocytes in patients with impaired glucose tolerance.

Zhang WY, Schwartz EA, Permana PA, Reaven PD.

Arterioscler Thromb Vasc Biol. 2008 Dec;28(12):2312-8. Epub 2008 Sep 25.PMID: 18818415 [PubMed - indexed for MEDLINE]Related articles

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT).

Saremi A, Anderson RJ, Luo P, Moritz TE, Schwenke DC, Allison M, Reaven PD; VADT.

Atherosclerosis. 2009 Apr;203(2):610-4. Epub 2008 Aug 5.PMID: 18804762 [PubMed - indexed for MEDLINE]Related articles

Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT).

Reaven PD, Emanuele N, Moritz T, Klein R, Davis M, Glander K, Duckworth W, Abraira C; Veterans Affairs Diabetes Trial.

Diabetes Care. 2008 May;31(5):952-7. Epub 2008 Mar 3.PMID: 18316393 [PubMed - indexed for MEDLINE]Related articlesFree article

Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women.

Martin M, Palaniappan LP, Kwan AC, Reaven GM, Reaven PD.

Diabetes Care. 2008 Apr;31(4):798-801. Epub 2008 Jan 17. Erratum in: Diabetes Care. 2008 Aug;31(8):1712. PMID: 18202246 [PubMed - indexed for MEDLINE]Related articlesFree article

Palmitic acid induces IP-10 expression in human macrophages via NF-kappaB activation.

Laine PS, Schwartz EA, Wang Y, Zhang WY, Karnik SK, Musi N, Reaven PD.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):150-5. Epub 2007 Apr 20.PMID: 17467667 [PubMed - indexed for MEDLINE]Related articles

The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers.

Abbasi F, Farin HM, Lamendola C, McLaughlin T, Schwartz EA, Reaven GM, Reaven PD.

J Clin Endocrinol Metab. 2006 Dec;91(12):5002-7. Epub 2006 Sep 26.PMID: 17003098 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular and signaling mechanisms of atherosclerosis in insulin resistance.

Schwartz EA, Reaven PD.

Endocrinol Metab Clin North Am. 2006 Sep;35(3):525-49, viii. Review.PMID: 16959584 [PubMed - indexed for MEDLINE]Related articles

Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study.

Wilson PW, Ben-Yehuda O, McNamara J, Massaro J, Witztum J, Reaven PD.

Atherosclerosis. 2006 Dec;189(2):364-8. Epub 2006 Feb 14.PMID: 16476434 [PubMed - indexed for MEDLINE]Related articles

Macrophage-secreted factors induce adipocyte inflammation and insulin resistance.

Permana PA, Menge C, Reaven PD.

Biochem Biophys Res Commun. 2006 Mar 10;341(2):507-14. Epub 2006 Jan 13.PMID: 16427608 [PubMed - indexed for MEDLINE]Related articles

Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes.

Abbasi F, Chang SA, Chu JW, Ciaraldi TP, Lamendola C, McLaughlin T, Reaven GM, Reaven PD.

Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R139-44.PMID: 16352858 [PubMed - indexed for MEDLINE]Related articles

Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications.

Israelian-Konaraki Z, Reaven PD.

Cardiol Rev. 2005 Sep-Oct;13(5):240-6. Review.PMID: 16106185 [PubMed - indexed for MEDLINE]Related articles

Exercise training is not associated with improved levels of C-reactive protein or adiponectin.

Marcell TJ, McAuley KA, Traustadóttir T, Reaven PD.

Metabolism. 2005 Apr;54(4):533-41.PMID: 15798963 [PubMed - indexed for MEDLINE]Related articles

Coronary artery and abdominal aortic calcification are associated with cardiovascular disease in type 2 diabetes.

Reaven PD, Sacks J; Investigators for the VADT.

Diabetologia. 2005 Feb;48(2):379-85. Epub 2005 Feb 2.PMID: 15688207 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular risk factors associated with insulin resistance in children persist into late adolescence.

Reaven PD, Traustadóttir T, Brennan J, Nader PR.

Diabetes Care. 2005 Jan;28(1):148-50. No abstract available. PMID: 15616249 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-alpha and atherosclerosis: from basic mechanisms to clinical implications.

Israelian-Konaraki Z, Reaven PD.

Cardiology. 2005;103(1):1-9. Epub 2004 Nov 2. Review.PMID: 15528894 [PubMed - indexed for MEDLINE]Related articles

Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes.

Reaven PD, Sacks J; Investigators for the Veterans Affairs Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2.

Diabetes Care. 2004 May;27(5):1115-20.PMID: 15111530 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women.

Abbasi F, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD.

Metabolism. 2004 Mar;53(3):280-3.PMID: 15015137 [PubMed - indexed for MEDLINE]Related articles

Discrimination between obesity and insulin resistance in the relationship with adiponectin.

Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD.

Diabetes. 2004 Mar;53(3):585-90.PMID: 14988241 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of frequency of coronary artery calcium in healthy Hispanic versus non-Hispanic white men by electron beam computed tomography.

Reaven PD, Thurmond D, Domb A, Gerkin R, Budoff MJ, Goldman S.

Am J Cardiol. 2003 Nov 15;92(10):1198-200.PMID: 14609596 [PubMed - indexed for MEDLINE]Related articles

Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers.

Harman SM, Liang L, Tsitouras PD, Gucciardo F, Heward CB, Reaven PD, Ping W, Ahmed A, Cutler RG.

Free Radic Biol Med. 2003 Nov 15;35(10):1301-9.PMID: 14607529 [PubMed - indexed for MEDLINE]Related articles

Managing lipid disorders: further evaluation of the VA-HIT.

Vajo Z, Reaven PD; Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

Curr Diab Rep. 2003 Jun;3(3):245-7. No abstract available. PMID: 12762973 [PubMed - indexed for MEDLINE]Related articles

Heart protection study: LDL lowering therapy and cardiovascular outcomes in patients with low cholesterol levels or diabetes.

Kulkarni M, Reaven PD.

Curr Diab Rep. 2002 Jun;2(3):269-73. No abstract available. PMID: 12643184 [PubMed - indexed for MEDLINE]Related articles

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.

Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB.

Free Radic Biol Med. 2003 Feb 15;34(4):409-18.PMID: 12566066 [PubMed - indexed for MEDLINE]Related articles

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.

Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.

Diabetes Care. 2002 Mar;25(3):542-9. Erratum in: Diabetes Care 2002 May;25(5):947. PMID: 11874944 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol.

Hayden JM, Brachova L, Higgins K, Obermiller L, Sevanian A, Khandrika S, Reaven PD.

J Lipid Res. 2002 Jan;43(1):26-35.PMID: 11792719 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.

Liguori A, Abete P, Hayden JM, Cacciatore F, Rengo F, Ambrosio G, Bonaduce D, Condorelli M, Reaven PD, Napoli C.

Eur Heart J. 2001 Nov;22(22):2075-84.PMID: 11686665 [PubMed - indexed for MEDLINE]Related articlesFree article

Cardiovascular disease in diabetes mellitus type 2: a potential role for novel cardiovascular risk factors.

Hayden JM, Reaven PD.

Curr Opin Lipidol. 2000 Oct;11(5):519-28. Review.PMID: 11048895 [PubMed - indexed for MEDLINE]Related articles

Lipoprotein modification and atherosclerosis in aging.

Reaven PD, Napoli C, Merat S, Witztumc JL.

Exp Gerontol. 1999 Jul;34(4):527-37. Review.PMID: 10817808 [PubMed - indexed for MEDLINE]Related articles

Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis.

Merat S, Fruebis J, Sutphin M, Silvestre M, Reaven PD.

J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):B85-94.PMID: 10737683 [PubMed - indexed for MEDLINE]Related articles

All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.

Lee C, Sigari F, Segrado T, Hörkkö S, Hama S, Subbaiah PV, Miwa M, Navab M, Witztum JL, Reaven PD.

Arterioscler Thromb Vasc Biol. 1999 Jun;19(6):1437-46.PMID: 10364074 [PubMed - indexed for MEDLINE]Related articlesFree article

Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.

Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD.

Arterioscler Thromb Vasc Biol. 1999 May;19(5):1223-30.PMID: 10323773 [PubMed - indexed for MEDLINE]Related articlesFree article

LDL isolated from Greek subjects on a typical diet or from American subjects on an oleate-supplemented diet induces less monocyte chemotaxis and adhesion when exposed to oxidative stress.

Tsimikas S, Philis-Tsimikas A, Alexopoulos S, Sigari F, Lee C, Reaven PD.

Arterioscler Thromb Vasc Biol. 1999 Jan;19(1):122-30.PMID: 9888874 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of dietary fatty acids in lipoprotein oxidation and atherosclerosis.

Tsimikas S, Reaven PD.

Curr Opin Lipidol. 1998 Aug;9(4):301-7. Review.PMID: 9739484 [PubMed - indexed for MEDLINE]Related articles

Liposomes enriched in oleic acid are less susceptible to oxidation and have less proinflammatory activity when exposed to oxidizing conditions.

Lee C, Barnett J, Reaven PD.

J Lipid Res. 1998 Jun;39(6):1239-47.PMID: 9643355 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese patients with type 2 diabetes.

Gumbiner B, Low CC, Reaven PD.

Diabetes Care. 1998 Jan;21(1):9-15.PMID: 9538963 [PubMed - indexed for MEDLINE]Related articlesFree article

Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL.

Sigari F, Lee C, Witztum JL, Reaven PD.

Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3639-45.PMID: 9437216 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidized low density lipoproteins in atherogenesis: role of dietary modification.

Reaven PD, Witztum JL.

Annu Rev Nutr. 1996;16:51-71. Review.PMID: 8839919 [PubMed - indexed for MEDLINE]Related articles

Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM.

Reaven PD, Herold DA, Barnett J, Edelman S.

Diabetes Care. 1995 Jun;18(6):807-16.PMID: 7555507 [PubMed - indexed for MEDLINE]Related articles

Susceptibility of human LDL to oxidative modification. Effects of variations in beta-carotene concentration and oxygen tension.

Reaven PD, Ferguson E, Navab M, Powell FL.

Arterioscler Thromb. 1994 Jul;14(7):1162-9.PMID: 8018673 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans.

Reaven PD, Grasse BJ, Tribble DL.

Arterioscler Thromb. 1994 Apr;14(4):557-66.PMID: 8148354 [PubMed - indexed for MEDLINE]Related articlesFree article

Mechanisms of atherosclerosis: role of LDL oxidation.

Reaven PD.

Adv Exp Med Biol. 1994;366:113-28. Review. No abstract available. PMID: 7771247 [PubMed - indexed for MEDLINE]Related articles

Studies on the ability of dietary supplementation with beta-carotene to protect low-density lipoprotein from oxidative modification.

Witztum JL, Reaven PD, Parthasarathy S.

Ann N Y Acad Sci. 1993 Dec 31;691:200-6. No abstract available. PMID: 8129290 [PubMed - indexed for MEDLINE]Related articles

Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans. Effects on lipid levels and lipoprotein susceptibility to oxidation.

Reaven PD, Witztum JL.

Arterioscler Thromb. 1993 Apr;13(4):601-8.PMID: 8466895 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.

Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL.

Arterioscler Thromb. 1993 Apr;13(4):590-600.PMID: 8466894 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of probucol dosage on plasma lipid and lipoprotein levels and on protection of low density lipoprotein against in vitro oxidation in humans.

Reaven PD, Parthasarathy S, Beltz WF, Witztum JL.

Arterioscler Thromb. 1992 Mar;12(3):318-24.PMID: 1547191 [PubMed - indexed for MEDLINE]Related articlesFree article